natgillin/translations-raw huggingface dataset:
For cats 9 weeks and older, two doses are given at an interval of 3 to 4 weeks.
Mačkam, starim 9 tednov ali več, damo dva odmerka v presledku 3 do 4 tedne.
When exposed to any of these viruses and bacterium later in life, the cat will either not become infected or will have a much less serious infection.
Če je mačka pozneje v življenju izpostavljena kateremu koli od teh virusov in bakteriji, se mačka ne bo okužila ali pa bo njena okužba blažja.
In the trial to observe side effects, there were no side effects in 94.2 % of cats for the first vaccination and no side effects observed for 99 % of cats for the second vaccination.
V preskušanju, v katerem so opazovali neželene učinke, po prvem cepljenju ni bilo nobenih neželenih učinkov pri 94,2 % mačk, po drugem pa pri 99 % mačk.
The European Commission granted a marketing authorisation valid throughout the European Union, for Fevaxyn Pentofel on 5 February 1997.
Evropska komisija je dovoljenje za promet z zdravilom Fevaxyn Pentofel, veljavno po vsej Evropski uniji, odobrila dne 5. februarja 1997.
In addition, studies in cats of various breeds were carried out to observe any side effects of Fevaxyn Pentofel after the first and second vaccinations.
Poleg tega so pregledali podatke študij na mačkah različnih pasem, da bi odkrili kakršne koli neželene učinke zdravila Fevaxyn Pentofel po prvem in drugem cepljenju.
If someone is accidentally injected with this product, they must seek immediate medical advice even if only a very small amount is injected.
Če vam je bil ta pripravek nenamerno injiciran, se takoj posvetujte z zdravnikom, čeprav je bila injicirana zelo majhna količina.
The benefit-risk balance may be found in the scientific discussion of this EPAR.
Razmerje med koristmi in tveganji najdete v znanstvene razprave tega Evropskega javnega poročila o oceni zdravila (EPAR).
Fevaxyn Pentofel contains small amounts of four inactivated viruses and one inactivated bacterium.
Zdravilo Fevaxyn Pentofel vsebuje majhne količine štirih inaktiviranih virusov in ene inaktivirane bakterije.
Fevaxyn Pentofel is then given once every year.
Zdravilo Fevaxyn Pentofel se daje enkrat letno.
When injected, this small exposure helps the cat's immune system to recognise and attack the viruses and bacterium.
Z injiciranjem zdravila izpostavimo mačko tem majhnim količinam, kar imunskemu sistemu mačke pomaga prepoznavati in napadati viruse in bakterijo.
Accidental injection may cause severe pain and swelling, particularly if injected into a joint or finger - rarely causing the loss of a finger.
Nenamerno injiciranje lahko povzroči hude bolečine in otekline, zlasti če se zdravilo injicira v sklep ali prst - in lahko v izjemnih primerih privede do izgube prsta.
Fevaxyn Pentofel contains mineral oil.
Zdravilo Fevaxyn Pentofel vsebuje mineralno olje.
In very rare cases there is an anaphylactic reaction (severe allergy) with oedema (fluid under the skin), pruritus, respiratory and cardiac distress, severe gastrointestinal signs or shock during the first hours after vaccination.
V zelo redkih primerih se pojavi anafilaktična reakcija (huda alergija), ki jo spremljajo edem (tekočina pod kožo), pruritus, dihalna in srčna stiska, hude gastrointestinalne motnje ali šok, ki se lahko pojavijo v prvih urah po cepljenju.
Occasionally there is swelling, pain, pruritus (itching) or hair loss at the injection site.
Včasih se pojavijo otekline, bolečine, pruritus (srbenje) ali izpadanje dlake na mestu injiciranja.
Other information about Fevaxyn Pentofel:
Druge informacije o zdravilu Fevaxyn Pentofel:
The contents of the prefilled syringe are shaken and given by subcutaneous (under the skin) injection.
Vsebino napolnjene brizge je treba pretresti in dati v obliki subkutane (podkožne) injekcije.
Some vaccinated cats may develop reactions to the vaccine, which include temporary fever, vomiting, anorexia (not eating), and/or depression, which usually disappear within 24 hours.
Pri nekaterih cepljenih mačkah se lahko pojavijo reakcije na cepivo, ki vključujejo začasno zvišanje telesne temperature, bruhanje, anoreksijo (neješčnost) in/ali depresijo.
The Committee for Medicinal Products for Veterinary Use (CVMP) agreed that the benefits of Fevaxyn Pentofel are greater than any risks to immunise healthy cats of 9 weeks or older against feline viruses.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je mnenja, da so koristi zdravila Fevaxyn Pentofel pri imunizaciji zdravih mačk, starih 9 tednov ali več, proti mačjim virusom večje od z njim povezanih tveganj.
Fevaxyn Pentofel is a vaccine for cats which is a solution for injection in a prefilled syringe.
Zdravilo Fevaxyn Pentofel je cepivo za mačke v obliki raztopine za injiciranje v napolnjeni injekcijski brizgi.
What benefit has Fevaxyn Pentofel shown during the studies?
Kakšne koristi je zdravilo Fevaxyn Pentofel izkazalo med raziskavami?
They recommended that Fevaxyn Pentofel should be given a marketing authorisation.
Odbor za zdravilo Fevaxyn Pentofel priporoča odobritev dovoljenja za promet.
The Package Leaflet should be taken to the doctor.
K zdravniku nesite tudi Navodila za uporabo.
Why has Fevaxyn Pentofel been approved?
Zakaj je bilo zdravilo Fevaxyn Pentofel odobreno?
An additional dose is recommended for kittens living in high-risk areas for feline leukaemia virus whose first dose was administered before 12 weeks of age.
Pri mačkah, ki živijo v območjih z velikim tveganjem za prenos virusa mačje leukemije in pri katerih je bil prvi odmerek dan pred starostjo 12 tednov, se priporoča dodaten odmerek.
How has the effectiveness of Fevaxyn Pentofel been studied?
Kako je bila učinkovitost zdravila Fevaxyn Pentofel raziskana?
Fevaxyn Pentofel contains the following inactivated viruses: feline panleukopenia virus, feline rhinotracheitis virus, feline calicivirus, feline leukaemia virus, and the inactivated bacterium feline Chlamydophila felis.
Zdravilo Fevaxyn Pentofel vsebuje naslednje inaktivirane viruse: virus mačje panleukopenije, virus mačjega rinotraheitisa, mačji calicivirus, virus mačje leukemije in inaktivirano bakterijo mačje Chlamydophila felis.
Fevaxyn Pentofel is used to immunise healthy cats of 9 weeks or older against feline panleukopenia and feline leukaemia and against respiratory diseases caused by feline rhinotracheitis virus, feline calicivirus and feline Chlamydophila felis.
Zdravilo Fevaxyn Pentofel se uporablja za imunizacijo zdravih mačk, starih 9 tednov ali več, proti mačji panleukopeniji in mačji leukemiji ter proti boleznim dihal, ki jih povzročajo virusi mačjega rinotraheitisa, mačji calicivirusi in mačja Chlamydophila felis.
What are the side effects of Fevaxyn Pentofel?
Kakšni so neželeni učinki zdravila Fevaxyn Pentofel?
How does Fevaxyn Pentofel work?
Kako zdravilo Fevaxyn Pentofel deluje?
What is Fevaxyn Pentofel used for?
Za kaj se zdravilo Fevaxyn Pentofel uporablja?
What is Fevaxyn Pentofel?
Kaj je zdravilo Fevaxyn Pentofel?
Fevaxyn Pentofel has been studied against Feline Leukaemia, against respiratory diseases caused by feline rhinotracheitis virus, feline calicivirus and feline Chlamydophila felis, as well as against disease caused by feline panleukopenia virus.
Zdravilo Fevaxyn Pentofel so preučevali proti mačji leukemiji, boleznim dihal, ki jih povzročajo virusi mačjega rinotraheitisa, mačji calicivirusi ter mačja Chlamydophila felis, in proti bolezni, ki jo povzroča virus mačje panleukopenije.
Fevaxyn Pentofel has been shown to be effective against Feline Leukaemia, against respiratory diseases caused by feline rhinotracheitis virus, feline calicivirus and feline Chlamydophila felis, as well as against disease caused by feline panleukopenia virus.
Dokazali so, da je zdravilo Fevaxyn Pentofel učinkovito proti mačji leukemiji, boleznim dihal, ki jih povzročajo virusi mačjega rinotraheitisa, mačji calicivirusi ter mačja Chlamydophila felis, in proti bolezni, ki jo povzroča virus mačje panleukopenije.
Invented name Strength Pharmaceutical Form Route of administration
Številka EU Zaščiteno ime Jakost Farmacevtska oblika
1 dose (0.5 ml) contains:
1 odmerek (0,5 ml) vsebuje: davični toksoid*
≥ 60 IU
10 mikrogramov
Diphtheria toxoid* ≥ 30 IU Tetanus toxoid*
tetanusni toksoid*
Inactivated Bordetella pertussis strain** ≥ 4 IU Hepatitis B virus surface Antigen recombinant** (S protein)*** 10 micrograms * adsorbed on aluminium oxide hydrated Total: 0.26 milligrams Al ** adsorbed on aluminium phosphate Total: 0.37 milligrams Al3+
*adsorbiran na aluminijev hidroksid skupno: 0,26 miligrama Al3+
*** produced on genetically-engineered yeast cells (Saccharomyces cerevisiae)
**adsorbiran na aluminijev fosfat skupno: 0,37 miligrama Al3+ ***pridobljen z genetskim inženiringom na celični kulturi kvasovk (Saccharomyces cerevisiae)
Packaging Content
Ovojnina
This can happen.
To se lahko zgodi.
Breathe in quickly and as deeply as you can.
Vdihnite hitro in globoko kolikor morete.
Date of first authorisation: 19 September 2013 Date of latest renewal: 22 May 2018
Datum prve odobritve: 19. september 2013 Datum zadnjega podaljšanja: 22. maj 2018
Hold breath Hold your breath for up to 5 seconds.
Zadržite dih Zadržite dih do 5 sekund.
Health-related quality of life:
Z zdravjem povezana kakovost življenja:
Supportive and symptomatic treatment is indicated.
Indicirano je podporno in simptomatsko zdravljenje.
You have not received enough of your medicine.
Niste prejeli dovolj zdravila.
In serious cases, patients should be hospitalised.
V resnih primerih je treba bolnika sprejeti v bolnišnico.
Daily activities
Vsakodnevne aktivnosti
Frequently Asked Questions
Pogosta vprašanja
If you use this medicine once a day, it will help to reduce the effects of COPD on your everyday life.
Če boste to zdravilo uporabljali enkrat na dan, vam bo pomagalo pri zmanjševanju vpliva KOPB na vaše vsakodnevno življenje.
Not all pack sizes may be available in your country.
V vaši državi morda niso na voljo vse velikosti pakiranj.
It is not harmful.
To vam ne bo škodovalo.
• voice alteration (hoarseness).
• spremembe glasu (hripavost)
Patients should be instructed not to take more than one dose in a day.
Bolnikom je treba naročiti, naj ne vzamejo več kot enega odmerka v istem dnevu.
A further 5% of the dose was found in the bile.
Nadaljnjih 5 % odmerka so našli v žolču.
Patients should be instructed on how to administer the medicinal product correctly.
Bolnike je treba poučiti, kako naj si pravilno aplicirajo zdravilo.
These patients should be monitored closely for potential adverse reactions.
Te bolnike je treba skrbno opazovati glede morebitnih neželenih učinkov.
Some side effects may be serious:
Nekateri neželeni učinki so lahko resni:
During inhalation you will hear a whirring noise.
Med vdihovanjem boste slišali brneč zvok.
If you get any of these serious side effects, seek medical help immediately.
Če pride do katerega od navedenih resnih neželenih učinkov, takoj poiščite zdravniško pomoč.
Needles and springs are made from stainless steel.
Igle in vzmeti so iz nerjavečega jekla.
Elderly (age 75 years and over) You can use this medicine if you are aged 75 years and over at the same dose as for other adults.
Starejši (stari 75 let ali več) Če ste stari 75 let ali več, lahko uporabljate to zdravilo v enakem odmerku kot drugi odrasli.
Week 26
1. dan po 26 tednih
No difference between ethnic subgroups was identified.
Razlik med pripadniki etničnih podskupin niso ugotovili.
The chances of the capsule breaking into small pieces will be increased if the capsule is pierced more than once.
Možnost, da se kapsula zdrobi v manjše delce, je večja, če kapsulo nehote predrete več kot enkrat.
Patients who do not experience improvement in breathing should be asked if they are swallowing the medicinal product rather than inhaling it.
Bolnike, pri katerih ne pride do izboljšanja dihanja, je treba vprašati, ali zdravilo morda pogoltnejo namesto da bi ga inhalirali.
• Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.
• ob vsakršni spremembi sistema za obvladovanje tveganj, zlasti kadar je tovrstna sprememba posledica prejema novih informacij, ki lahko privedejo do znatne spremembe razmerja med koristmi in tveganji, ali kadar je ta sprememba posledica tega, da je bil dosežen pomemben mejnik (farmakovigilančni ali povezan z manjševanjem tveganja).
Carcinogenicity was assessed in a two-year rat study and a six-month transgenic mouse study.
Kancerogenost so ocenjevali v dvoletni študiji na podganah in v šestmesečni študiji na transgenskih miših.
However, this medicine may cause dizziness (see section 4).
Lahko pa to zdravilo povzroča omotičnost (glejte poglavje 4).
Then, inhale the next dose as usual the next day.
Naslednjega dne inhalirajte odmerek kot običajno.
Place the mouthpiece in your mouth and close your lips firmly around it.
Ustnik namestite v usta in ga čvrsto objemite z ustnicami.
Do not inhale more than one dose on the same day.
Na isti dan ne inhalirajte več kot en odmerek zdravila.
If you feel dizzy while taking this medicine, do not drive or use machines.
Če v času jemanja tega zdravila čutite omotičnost, ne vozite in ne upravljajte strojev.
Information on the potential for interactions is based on the potential for each of its two active substances.
Podatki o možnih interakcijah temeljijo na možnih interakcijah vsake posamezne od obeh učinkovin zdravila.
The effect remains constant over the whole 24-h dosing interval.
Delovanje ostaja enako učinkovito v celotnem 24-urnem odmernem intervalu.
For instructions on use of the medicinal product before administration, see section 6.6.
Za navodila glede rokovanja z zdravilom pred dajanjem glejte poglavje 6.6.
As long as the capsule is empty you have received enough of your medicine.
Če ste kapsulo izpraznili, ste prejeli dovolj zdravila.
This medicine contains lactose (23.5 mg per capsule).
To zdravilo vsebuje laktozo (23,5 mg na kapsulo).
You only need to inhale once a day because the effect of this medicine lasts for 24 hours.
To zdravilo morate inhalirati samo enkrat na dan, saj deluje 24 ur.
Each blister contains either 6 or 10 hard capsules.
Vsak pretisni omot vsebuje 6 ali 10 trdih kapsul.
There are no data on the use of this medicine in pregnant women and it is not known whether the active substances of this medicine pass into human milk.
O uporabi tega zdravila v nosečnosti ni na voljo nobenih podatkov in prav tako ni znano, ali zdravilni učinkovini tega zdravila prehajata v materino mleko.
- Tell your doctor immediately if your COPD symptoms such as breathlessness, wheezing or cough do not improve or get worse.
- Takoj obvestite zdravnika, če se simptomi KOPB, kot so zadihanost, piskanje v pljučih ali kašelj, ne izboljšajo ali če se poslabšajo.
Do not use more than your doctor tells you to use.
Ne uporabljajte večjega odmerka, kot vam je naročil vaš zdravnik.
These belong to a group of medicines called bronchodilators.
Sodita v skupino zdravil z imenom bronhodilatatorji.
What should I do if there is powder left inside the capsule?
Kaj naj naredim, če je v kapsuli še prašek?
Pharmacotherapeutic group: Drugs for obstructive airway diseases, adrenergics in combination with anticholinergics, ATC code: R03AL04
Farmakoterapevtska skupina: Zdravila za obstruktivne pljučne bolezni, adrenergiki v kombinaciji z antiholinergiki, oznaka ATC: R03AL04
Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first.
Znotraj vsakega organskega sistema so neželeni učinki razvrščeni po pogostnosti, pri čemer so najbolj pogosti navedeni najprej.
The maximal effect on blood glucose was 0.67 mmol/l.
Največji učinek na koncentracijo glukoze v krvi je bil 0,67 mmol/l.
It is unlikely that this medicine will affect your ability to drive and use machines.
Malo verjetno je, da bi to zdravilo vplivalo na vašo sposobnost upravljanja vozil in strojev.
It did not suggest any difference between ethnic subgroups in this population.
Na podlagi te analize ne kaže, da bi med posameznimi etničnimi podskupinami te populacije obstajale kakršnekoli razlike.
Also contains: lactose and magnesium stearate.
Vsebuje tudi: laktozo in magnezijev stearat.
In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000, <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Pri tem razvrstitev posameznega neželenega učinka v ustrezno kategorijo pogostnosti temelji na naslednjem dogovoru: zelo pogosti (≥1/10); pogosti (≥1/100 do <1/10); občasni (≥1/1.000 do <1/100); redki (≥1/10.000 do <1/1.000); zelo redki (<1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov).
If you use more Ultibro Breezhaler than you should If you have inhaled too much of this medicine or if someone else accidentally uses your capsules, you must immediately either tell your doctor or go to the nearest emergency unit.
Če ste uporabili večji odmerek zdravila Ultibro Breezhaler, kot bi smeli Če ste vdihnili preveč tega zdravila ali če kdo drug pomotoma uporabi vaše kapsule, takoj obvestite zdravnika ali pojdite do najbližjega oddelka za nujno pomoč.
If a dose is missed, it should be taken as soon as possible on the same day.
V primeru izpuščenega odmerka je treba zdravilo vzeti čimprej še isti dan.
After intravenous infusion the volume of distribution of indacaterol during the terminal elimination phase was 2557 litres indicating an extensive distribution.
Po intravenski infuziji je bil volumen porazdelitve indakaterola v obdobju končne faze izločanja 2.557 litrov, kar kaže na obsežno porazdelitev.
Do not give this medicine to children or adolescents below the age of 18 years.
Tega zdravila ne dajajte otrokom ali mladostnikom, ki so stari manj kot 18 let, ker uporaba zdravila v tej starostni skupini ni bila proučena.
Pierce capsule by firmly pressing both side buttons at the same time.
Kapsulo predrete tako, da oba stranska gumba istočasno močno stisnete.
Shortening of electrocardiograph intervals and decreased systolic and diastolic blood pressure were also apparent.
Opažali so tudi krajšanje intervalov pri elektrokardiografiji ter zniževanje sistoličnega in diastoličnega krvnega tlaka.
FEV1 AUC:
AUC vrednosti FEV1:
Do not use this medicine to treat a sudden attack of breathlessness or wheezing.
Tega zdravila ne uporabljajte za zdravljenje nenadnih napadov zadihanosti ali piskajočega dihanja.
• Do not blow into the mouthpiece.
• Ne pihajte v ustnik.
There was no attenuation of the bronchodilator effect over time.
Bronhodilatatoren učinek se s časom ni zmanjševal.
The apparent volume of distribution in the terminal phase following inhalation was almost 20-fold larger, which reflects the much slower elimination after inhalation.
Po inhalaciji je bil navidezni volumen porazdelitve v terminalni fazi skoraj 20-krat večji, kar odraža precej počasnješe izločanje učinkovine po inhalaciji.
Inhalation powder, hard capsule
prašek za inhaliranje, trda kapsula
When compared with the serum clearance of indacaterol of 23.3 litres/hour, it is evident that renal clearance plays a minor role (about 2 to 5% of systemic clearance) in the elimination of systemically available indacaterol.
Primerjava s serumskim očistkom indakaterola 23,3 litra/uro jasno kaže, da ima izločanje preko ledvic le majhno vlogo (približno 2 do 5 % sistemskega očistka) pri izločanju sistemsko razpoložljivega indakaterola.
In case such effects occur with this medicinal product, treatment may need to be discontinued.
Če pride do takega vpliva pri uporabi tega zdravila, je včasih treba zdravljenje prekiniti.
• One or more blister cards, each containing either
• en ali več pretisnih omotov, vsak vsebuje 6 ali
In four of these studies patients were enrolled who had a clinical diagnosis of moderate to severe COPD.
V štiri od navedenih študij so bili vključeni bolniki, ki so imeli klinično diagnozo zmerne do hude KOPB.
Rare (may affect up to 1 in 1000 people) • tingling or numbness.
Redki (lahko se pojavijo pri največ 1 od 1.000 bolnikov) • mravljinčenje ali odrevenelost
Glycopyrronium bromide (including its metabolites) was excreted into the milk of lactating rats and reached up to 10-fold higher concentrations in the milk than in the blood of the dam.
Glikopironijev bromid se je (vključno s presnovki) izločal v mleko doječih podgan in je v mleku dosegal do 10-krat višjo koncentracijo kot v krvi samice.
To be taken into account with concomitant use
Pri sočasni uporabi je treba vzeti v obzir
Indacaterol serum concentrations declined in a multi-phasic manner with an average terminal half-life ranging from 45.5 to 126 hours.
Koncentracija indakaterola v serumu upada v več fazah s povprečnim končnim razpolovnim časom v razponu od 45,5 do 126 ur.
In clinical studies, the amount of indacaterol excreted unchanged via urine was generally lower than 2.5% of the delivered dose.
V kliničnih študijah je bil delež nespremenjenega indakaterola, ki se je izločil z urinom, večinoma manjši od 2,5 % prejetega odmerka.
This medicine blocks the tightening of these muscles in the lungs, making it easier for air to get in and out of the lungs.
To zdravilo zmanjša napetost teh mišic v pljučih, tako da zrak laže vstopi v pljuča in izstopi iz njih.
Why didn't the inhaler make a noise when I inhaled?
Zakaj med inhalacijo ni bilo slišati brnenja inhalatorja?
Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity at clinically relevant exposures (see section 5.3).
Študije na živalih ne kažejo neposrednih ali posrednih škodljivih učinkov na sposobnost razmnoževanja pri klinično pomembnih izpostavljenostih zdravilu (glejte poglavje 5.3).
Cleaning the inhaler Wipe the mouthpiece inside and outside with a clean, dry, lint-free cloth to remove any powder residue.
Čiščenje inhalatorja Ustnik z notranje in zunanje strani očistite s čisto, suho krpico, ki ne pušča vlaken, da odstranite ostanke praška.
The capsules must be administered only using the Ultibro Breezhaler inhaler (see section 6.6).
Kapsule so namenjene samo uporabi z inhalatorjem Ultibro Breezhaler (glejte poglavje 6.6).
You may notice that your heart is beating faster than usual, or you may have a headache, feel drowsy, feel nauseous or have to vomit, or you may notice visual disturbances, feel constipated or have difficulty when passing urine.
Morda boste opažali, da vam srce bije hitreje kot običajno, morda vas bo bolela glava ali pa boste zaspani, vam bo slabo ali vas bo sililo na bruhanje, morda pa boste opažali motnje vida, zaprtost ali oteženo odvajanje urina.
All these findings occurred at exposures sufficiently in excess of those anticipated in humans.
Do vseh navedenih sprememb je prišlo pri izpostavljenosti, ki je v zadostni meri presegala predvideno izpostavljenost pri ljudeh.
• crushing chest pain with increased sweating - this may be a serious heart problem (ischaemic heart disease).
• stiskajoča bolečina v prsih s povečanim znojenjem - lahko gre za resne težave s srcem (za ishemično bolezen srca);
- The other ingredients of the inhalation powder are lactose monohydrate and magnesium stearate (see section 2 under “Ultibro Breezhaler contains lactose”).
- Drugi sestavini inhalacijskega praška sta laktoza monohidrat in magnezijev stearat (glejte poglavje 2 pod “Zdravilo Ultibro Breezhaler vsebuje laktozo”).
6 x 1 capsules + 1 inhaler 10 x 1 capsules + 1 inhaler 12 x 1 capsules + 1 inhaler 30 x 1 capsules + 1 inhaler 90 x 1 capsules + 1 inhaler
6 x 1 kapsula + 1 inhalator 10 x 1 kapsul + 1 inhalator 12 x 1 kapsula + 1 inhalator 30 x 1 kapsula + 1 inhalator 90 x 1 kapsula + 1 inhalator
If this happens, carefully loosen the capsule by tapping the base of the inhaler.
Če se to zgodi, previdno sprostite kapsulo z rahlim trkanjem ob spodnji del inhalatorja.
The recommended dose is the inhalation of the content of one capsule once daily using the Ultibro Breezhaler inhaler.
Priporočeni odmerek je inhalacija vsebine ene kapsule enkrat na dan z uporabo inhalatorja Ultibro Breezhaler.